ENDOCRINE SYSTEM DISEASES

This study tested whether a new antibody drug called LASN01 can help people with moderate-to-severe thyroid eye disease. Forty-one patients received either the drug or a placebo to see if it reduces eye bulging and inflammation. The trial specifically looked at patients who hadn'…

This trial tested whether a daily injection called TransCon PTH could help adults with hypoparathyroidism better control their blood calcium levels. For the first 26 weeks, some participants received the real injection while others received a placebo, and neither they nor their d…

This study tested a new endoscopic procedure that aims to regenerate the lining of the small intestine to help control type 2 diabetes. Researchers enrolled 20 adults whose diabetes wasn't well-controlled on 2-3 non-insulin medications. The main goal was to check if the procedure…

This study tested whether a daily injection of a hormone called TransCon PTH could help adults with hypoparathyroidism. The goal was to see if the treatment could help patients maintain normal calcium levels in their blood while stopping or reducing their need for high-dose vitam…

This small pilot study tested whether helping people with diabetes manage their medical costs and connecting them with a supportive peer could improve their health. 61 adults with diabetes who reported financial stress were randomly assigned to receive either financial help alone…

This study followed adults with growth hormone deficiency who had already completed a previous trial. It aimed to see if a weekly injection of the hormone lonapegsomatropin was safe and effective for long-term use. Researchers tracked side effects and measured changes in body fat…

This study tested a medication called tirzepatide in children and teenagers (ages 10-17) whose type 2 diabetes was not well-controlled with standard treatments like metformin or insulin. Over 60 weeks, researchers compared the drug to a placebo to see if it could better lower blo…

This study investigated how COVID-19 affects the body's hormone systems and whether people with existing hormone problems face worse outcomes. Researchers followed 220 hospitalized COVID-19 patients, testing their blood for hormone levels and inflammation markers during and after…